3. Umbruch 4.4..2005 - Online Pot

Role of the endocannabinoid system in learning and memory 135
58 Richfield EK, Herkenham M (1994) Selective vulnerability in Huntington’s disease: preferential
loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36: 577–584
59 Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J (2003) Cannabinoid
CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic
plaque-associated glia in Alzheimer’s disease brains. J Neurosci 23: 11136–11141
60 Mazzola C, Micale V, Drago F (2003) Amnesia induced by beta-amyloid fragments is counteracted
by cannabinoid CB1 receptor blockade. Eur J Pharmacol 477: 219–225
61 Lichtman AH, Martin BR (1996) ∆ 9 -Tetrahydrocannabinol impairs spatial memory through a
cannabinoid receptor mechanism. Psychopharmacology 126: 125–131
62 Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G (2004) CB1 cannabinoid
receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.
Learn Memory 11: 625–632
63 Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory reconsolidation
and extinction have distinct temporal and biochemical signatures. J Neurosci 24:
4787–4795
64 Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued
and contextual fear conditioning. Behav Neurosci 106: 274–285
65 Varvel SA, Anum E, Lichtman AH (2005) Disruption of CBI receptor signaling impairs extinction
of spatial memory in mice. Psychopharmacology; in press
66 Parker LA, Burton P, Sorge RE, Yakiwchuk C, Mechoulam R (2004) Effect of low doses of
Delta(9)-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced
conditioned place preference learning in rats. Psychopharmacology (Berl) 175:
360–366
67 Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI (1997) SR141716A is an
inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol 334: R1–R2
68 Pan X, Ikeda SR, Lewis DL (1998) SR 141716A acts as an inverse agonist to increase neuronal
voltage-dependent Ca 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. American
Society for Pharmacology and Experimental Therapeutics 54: 1064–1072
69 Sim LJ, Selley DE, Xiao R, Childers SR (1996) Differences in G-protein activation by µ- and
∆-opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol 307: 97–105
70 Burkey TH, Quock RM, Consroe P, Roeske WR, Yamamura HI (1997) ∆ 9 -Tetrahydrocannabinol
is a partial agonist of cannabinoid receptors in mouse brain. Eur J Pharmacol 323: R3–R4
71 Burkey TH, Quock RM, Consroe P, Ehlert FJ, Hosohata Y, Roeske WR, Yamamura HI (1997)
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur J Pharmacol
336: 295–298
72 Sim-Selley LJ, Brunk LK, Selley DE (2001) Inhibitory effects of SR141716A on G-protein activation
in rat brain. Eur J Pharmacol 414: 135–143
73 Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani
J, Néliat G, Caput D et al. (1994) SR141716A, a potent and selective antagonist of the brain
cannabinoid receptor. FEBS Lett 350: 240–244
74 Compton D, Aceto M, Lowe J, Martin B (1996) In vivo characterization of a specific cannabinoid
receptor antagonist (SR141716A): Inhibition of ∆ 9 -tetrahdrocannabinol-induced responses and
apparent agonist activity. J Pharmacol Exp Ther 277: 586–594
75 Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of
glutamatergic synaptic transmission in the hippocampus. Neuroscience 106: 1–4
76 Hajos N, Freund T (2002) Pharmacological separation of cannabinoid sensitive receptors on hippocampal
excitatory and inhibitory fibers. Neuropharmacology 43: 503
77 Mogil JS, Grisel JE (1998) Transgenic studies of pain. Pain 77: 107–128
78 Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991)
Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro
autoradiographic study. J Neurosci 11: 563–583
79 Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, Brelière JC, Soubrié P, Le
Fur G (1996) Characterization and distribution of binding sites for [ 3 H]-SR 141716A a selective
brain (CB1) cannabinoid receptor antagonist in rodent brain. Life Sci 58: 1239–1247
80 Matsuda LA, Bonner TI, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat
brain. J Comp Neurol 327: 535–550
81 Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels
in cultured rat hippocampal neurons. Amer Physiol Soc 78: 43–50